Search Results

You are looking at 1 - 4 of 4 items for :

Clear All
Open access

Dragana Pavlović Breneselović and Živka Krnjaja

the Developing Child, Harvard University. OECD (2010). Razumeti mozak: Rođenj enauke o učenju [Understanding the brain]. Beograd: OECD/Ministarstvo prosvete RS. Olfman, S., (2009). The sexualization of childhood: Growing older younger/growing younger older. In S. Olfman (Ed.). The sexualization of childhood (pp. 1-7). Westport, CT: Praeger Publishers. O’Kane, C. (2008). The development of participatory techniques: Facilitating children’s views about decisions which affect them. In P. Christensen, & A. James (Eds

Open access

Borislav Kondov, Goran Kondov, Zoran Spirovski, Zvonko Milenkovikj, Risto Colanceski, Gordana Petrusevska and Meri Pesevska

review.Lancet Oncol. 2014 Jul;15(8):e351-62. 13. W. Byon, E. Kim, J. Kwon, BJ.Song, C. Park. FDG-PET, MRI and USG in the assessment of axillary lymph node metastases in breast cancer- The Breast 24S1 (2015) S67. 14. Hwang SO1, Lee SW, Kim HJ, Kim WW, Park HY, Jung JH. The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18) F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer.J Breast Cancer. 2013 Sep;16(3):315-21. 15. Hyun SJ, Kim EK, Yoon JH, Moon HJ, Kim MJ. Adding MRI to

Open access

Zorica Naumovska, Aleksandra K. Nesterovska, Ana Filipce, Zoran Sterjev, Katerina Brezovska, Aleksandar Dimovski and Ljubica Suturkova

risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition. Clin Pharmacol Ther. 2005; 78: 43-51. 48. Wang D, Johnson AD, Papp AC, Kroetz DE and Sade´e W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics. 2005; 15: 693-704. 49. Verstuyft C, Schwab M, Schaeffeler E, et al. Digoxin pharmacokinetics and MDR1 genetic polymorphisms. Eur J Clin Pharmacol. 2003; 58: 809-812. 50. Mickley LA, Lee JS, Weng Z, et al. Genetic polymorphism in MDR

Open access

V. Micheli, M. Bertelli, G. Jacomelli, A. Santucci and G. Bernardini

]. Neurochemical analysis of post mortem tissues revealed dysfunction of brain neurotransmitters, with decreased dopaminergic neuron terminals in the striatum and increased amount of serotonin and 5-hydroxyindolacetate [ 56 ]. Decreased levels of the dopamine (DA) metabolite homovanillic acid, together with increased hypoxanthine and xanthine concentrations were found in LND patient’s cerebrospinal fluid [ 57 ]. PET neurochemical and neuroimaging in vivo studies performed in LND patients demonstrated significant abnormalities of DA neuron function in the basal ganglia